Clinical Report: Updated Meta-Analysis on TNF-α Polymorphisms and SLE

Overview

This meta-analysis investigates the association between TNF-α-308G/A and TNF-α-238G/A polymorphisms and susceptibility to systemic lupus erythematosus (SLE). The findings indicate that TNF-α-308G/A is linked to increased SLE susceptibility.

Background

Systemic lupus erythematosus (SLE) is a complex autoimmune disease with significant genetic contributions to its susceptibility. Understanding the genetic factors, such as TNF-α polymorphisms, is crucial for elucidating the pathogenesis of SLE and developing targeted therapies. Previous studies have yielded inconsistent results regarding these associations, necessitating a comprehensive meta-analysis.

Data Highlights

Key Findings

• TNF-α-308G/A polymorphism is associated with heightened SLE susceptibility across various populations.
• No significant association was found for TNF-α-238G/A polymorphism regarding SLE susceptibility in the initial analysis.
• Subsequent sensitivity analyses indicated a correlation between TNF-α-238G/A and increased SLE susceptibility in mixed populations.
• Four significant associations had BFDP values exceeding 0.80, suggesting they may be false positives.
• The 95% prediction interval excluded the null value for only two significant associations.

Clinical Implications

The findings indicate that TNF-α-308G/A may be a credible genetic marker for SLE susceptibility. The association of TNF-α-238G/A requires cautious interpretation.

Conclusion

This meta-analysis highlights the need for careful evaluation of significant findings in genetic associations with SLE.

Related Resources & Content

1. Clinical Rheumatology, 2025 -- Link Between the T Allele of rs2431697 at 5q33.3 and Systemic Lupus Erythematosus: A Case-Control Investigation and Meta-Analysis
2. Clinical Rheumatology, 2019 -- Genetic Variants of the Human Glucocorticoid Receptor in Systemic Lupus Erythematosus: Findings from a Single-Center Study
3. Blood Cancer Journal, 2022 -- Meta-analysis Across the Genome Reveals Risk Loci Associated with Monoclonal Gammopathy of Undetermined Significance (MGUS) and IRF-6 Impact
4. New Lupus SLE Clinical Practice Guideline Released | ACR Convergence 2025 | American College of Rheumatology
5. Clinical Rheumatology — Genetic Variants in NLRP3 and Their Relationship to Primary Gouty Arthritis Risk in a Han Chinese Cohort
6. Efficacy and Safety of Obinutuzumab in Active Lupus Nephritis
7. The 330 risk loci known for systemic lupus erythematosus (SLE): a review
8. New Lupus SLE Clinical Practice Guideline Released | ACR Convergence 2025 | American College of Rheumatology